EMTHERAPRO INC

From the company

Emtherapro provides a next generation precision medicine enablement solution for neurodegenerative diseases, empowering biotech, life sciences and pharmaceutical companies to develop diagnostics and therapies. Anchored in proteomics, it integrates clinical, pathological, genetic and other omics data to advance biomarker discovery and validation for risk profiling, diagnosis, monitoring, prognosis and safety.